Analysis of the effects of HIV-1 Tat on the survival and differentiation of vessel wall-derived mesenchymal stem cells

Journal of Cellular Biochemistry

Volumn 113, Issue 4, 2012, Pages 1132-1141

  Gibellini, Davide ^a   Miserocchi, Anna ^a   Tazzari, Pier Luigi ^a   Ricci, Francesca ^a   Clò, Alberto ^a   Morini, Silvia ^a   Ponti, Cristina ^b   Pasquinelli, Gianandrea ^c   Bon, Isabella ^a   Pagliaro, Pasqualepaolo ^a   Borderi, Marco ^c   Re, Maria Carla ^a,d  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

Author keywords

APOPTOSIS; DIFFERENTIATION; HIV 1; MESENCHYMAL STEM CELLS; Tat

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SEMAXANIB; TRANSACTIVATOR PROTEIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VON WILLEBRAND FACTOR;

ADIPOGENESIS; ADULT; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; CELL WALL; DOWN REGULATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; UPREGULATION; VIRUS REPLICATION;

ADULT; APOPTOSIS; BLOOD VESSELS; CELL DIFFERENTIATION; CELL SURVIVAL; FLOW CYTOMETRY; GENE PRODUCTS, TAT; HIV-1; HUMANS; MALE; MESENCHYMAL STEM CELLS; REAL-TIME POLYMERASE CHAIN REACTION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84857545205     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23446     Document Type: Article

References (51)

1. Albini A, Soldi R, Giunciglio D, Giraudo E, Benelli R, Primo L, Noonan D, Saglio M, Camussi G, Rockl W, Bussolino F,. 1996. The angiogenesis induced by HIV-1 Tat is mediated by the Flk-1/KDR receptor on vascular endothelial cells. Nat Med 2: 1371-1375.
2. Alviano F, Fossati V, Marchionni C, Arpinati M, Bonsi L, Franchina M, Lanzoni G, Cantoni S, Cavallini C, Bianchi F, Tazzari PL, Pasquinelli G, Foroni L, Ventura C, Grossi A, Bagnara GP,. 2007. Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro. BMC Dev Biol 7: 11.
3. Barillari G, Ensoli E,. 2002. Angiogenic effects of extracellular Human Immunodeficiency Virus Type 1 Tat protein and its role in the pathogenesis of AIDS-Associated Kaposi's Sarcoma. Clin Microbiol Rev 15: 310-326.
4. Barillari G, Gendelman R, Gallo RC, Ensoli B,. 1993. The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc Natl Acad Sci USA 90: 7941-7945.
5. Barillari G, Sgadari C, Fiorelli V, Samaniego F, Colombini S, Manzari V, Modesti V, Nair BC, Cafaro A, Sturzl M, Ensoli B,. 1999a. The Tat protein of human immunodeficiency virus type 1 promotes vascular cell growth and locomotion by engaging the α5β1 and αvβ3 integrins and by mobilizing sequestered basic fibroblast growth factor. Blood 94: 663-672.
6. Barillari G, Sgadari C, Palladino C, Gendelman R, Caputo A, Morris CB, Nair BC, Markham P, Nel A, Sturzl M, Ensoli B,. 1999b. Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the αvβ3 integrin. J Immunol 163: 1929-1935.
7. Barqasho B, Nowak P, Tjernlund A, Kinloch S, Goh LE, Lampe F, Fisher M, Andersson J, Sönnerborg A,. 2009. QUEST study group: Kinetics of plasma cytokines and chemokines during primary HIV-1 infection and after analytical treatment interruption. HIV Med 10: 94-102.
8. Brown TT,. 2011. The effects of HIV-1 infection on endocrine organs. Best Pract Res Clin Endocrinol Metabol 25: 403-411.
9. Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA,. 1999. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor- associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: A cohort study. Lancet 353: 2093-2099.
10. Cotter EJ, Ip HSM, Powderly WG, Doran PP,. 2008. Mechanism of HIV protein induced modulation of mesenchymal stem cell osteogenic differentiation. BMC Musculoskel Disord 9: 33.
11. Cotter EJ, Chew N, Powderly WG, Doran PP,. 2011. HIV type 1 alters mesenchymal stem cell differentiation potential and cell phenotype ex-vivo. AIDS Res Hum Retrov 27: 187-199.
12. Crowe SM, Westhorpe CLV, Mukhamedova N, Jawororowski A, Sviridov D, Burkinsky M,. 2010. The macrophage: The intersection between HIV infection and atherosclerosis. J Leukoc Biol 87: 589-598.
13. Dayton AI, Sodroski JG, Rosen CA, Goh WC, Haseltine WA,. 1986. The trans-activator gene of the human T cell lymphotropic virus type III is required for replication. Cell 44: 941-947.
14. Ensoli B, Buonaguro L, Barillari G, Fiorelli V, Gendelmann R, Morgan RA, Wingfield P, Gallo RC,. 1993. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol 67: 277-287.
15. Ergun S, Hohn HP, Kilic N, Singer BB, Tilki D,. 2008. Endothelial and hematopoietic progenitor cells (EPCs and HPCs): Hand in hand fate determining partners for cancer cells. Stem Cell Rev 4: 169-177.
16. Frankel AD, Pabo CO,. 1988. Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 55: 1189-1193.
17. Gibellini D, Vitone F, Schiavone P, Re MC,. 2005a. HIV-1 Tat protein and cell proliferation and survival: A brief review. New Microbiol 28: 95-109.
18. Gibellini D, Re MC, Ponti C, Vitone F, Bon I, Fabbri G, Grazia Di Iasio M, Zauli G,. 2005b. HIV-1 Tat protein concomitantly down-regulates apical caspase-10 and up-regulates c-FLIP in lymphoid T cells: A potential molecular mechanism to escape TRAIL cytotoxicity. J Cell Physiol 203: 547-556.
19. Gibellini D, De Crignis E, Ponti C, Borderi M, ClÒ A, Miserocchi A, Viale P, Re MC,. 2010. HIV-1 Tat protein enhances RANKL/M-CSF-mediated osteoclast differentiation. Biochem Biophys Res Commun 401: 429-434.
20. Gibellini D, Alviano F, Miserocchi A, Tazzari P, Ricci F, Clo A, Morini S, Borderi M, Viale P, Pasquinelli G, Pagliaro P, Bagnara GP, Re MC,. 2011. HIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall derived mesenchymal stem cells. Retrovirology 8: 40.
21. Grünewald FS, Prota AE, Giese A, Ballmer-Hofer K,. 2010. Structure-function analysis of VEGF receptor activation and the role of coreceptors in angiogenic signaling. Biochim Biophys Acta 1804: 567-580.
22. Grunfeld C, Kotler DP, Hamadeh R, Tierney A, Wang J, Pierson RN,. 1989. Hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med 86: 27-31.
23. Grunfeld C, Pang M, Doerrler W, Shigenaga JK, Jensen P, Feingold KR,. 1992. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metabol 74: 1045-1052.
24. Hakeem A, Bhatti S, Cilingiroglu M,. 2010. The spectrum of atherosclerotic coronary artery disease in HIV patients. Curr Atheroscler Rep 12: 119-124.
25. Hsue PY, Hunt PW, Schnell A, Kalapus SC, Hoh R, Ganz P, Martin JN, Deeks SG,. 2009. Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis. AIDS 23: 1059-1067.
26. Jia H, Lohr M, Jezequel S, Davis D, Shaikh S, Selwood D, Zachary I,. 2001. Cysteine-rich and basic domain HIV-1 Tat peptides inhibit angiogenesis and induce endothelial cell apoptosis. Biochem Biophys Res Commun 283: 469-479.
27. Kanmogne GD, Kennedy RC, Grammas P,. 2001. Analysis of human lung ECs for susceptibility to HIV type 1 infection, coreceptor expression, and cytotoxicity of gp120 protein. AIDS Res Hum Retroviruses 17: 45-53.
28. Klein D, Hohn HP, Kleff V, Tilkl D, Ergun S,. 2010. Vascular wall-resident stem cells. Histol Histopathol 25: 681-689.
29. Laspia MF, Rice AP, Mathews MB,. 1989. HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell 59: 283-292.
30. Lawson VA, Silburn KA, Gorry PR, Paukovic G, Purcell DF, Greenway AL, McPhee DA,. 2004. Apoptosis induced in synchronized human immunodeficiency virus type 1-infected primary peripheral blood mononuclear cells is detected after the peak of CD4+ T-lymphocyte loss and is dependent on the tropism of the gp120 envelope glycoprotein. Virology 327: 70-82.
31. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA,. 1995. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 270: 12953-12956.
32. Levy JA,. 2009. HIV pathogenesis: 25 years of progress and persistent challenges. AIDS 23: 147-160.
33. Liu X, Jana M, Dasgupta S, Koka S, He J, Wood C, Pahan K,. 2002. Human immunodeficiency virus type 1 (HIV-1) tat induces nitric-oxide synthase in human astroglia. J Biol Chem 277: 39312-39319.
34. Lorenz MW, Stephan C, Harmjanz A, Staszewski S, Buehler A, Bickel M, von Kegler S, Ruhkamp D, Steinmetz H, Sitzer M,. 2008. Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis. Atherosclerosis 196: 720-726.
35. Mameli G, Deshmane SL, Ghafouri M, Cui J, Simbiri K, Khalili K, Mukerjee R, Dolei A, Amini S, Sawaya BE,. 2007. C/EBPβ regulates human immunodeficiency virus 1 gene expression through its association with cdk9. J Gen Virol 88: 631-640.
36. Milani D, Mazzoni M, Zauli G, Mischiati C, Gibellini D, Giacca M, Capitani S,. 1998. HIV-1 Tat induces tyrosine phosphorylation of p125FAK and its association with phosphoinositide 3-kinase in PC12 cells. AIDS 12: 1275-1284.
37. Mitola S, Sozzani S, Luini W, Primo L, Bosatti A, Weich H, Bussolino F,. 1997. Tat-human immunodeficiency virus-1 induces human monocyte chemotaxis by activation of vascular endothelial growth factor receptor-1. Blood 90: 1365-1372.
38. Montesinos JJ, Flores-Figueroa E, Castillo-Medina S, Flores-Guzmán P, Hernández-Estévez E, Fajardo-Orduña G, Orozco S, Mayani H,. 2009. Human mesenchymal stromal cells from adult and neonatal sources: Comparative analysis of their morphology, immunophenotype, differentiation patterns and neural protein expression. Cytotherapy 11: 163-176.
39. Mu H, Chai H, Lin PH, Yao Q, Chen C,. 2007. Current update on HIV-associated vascular diseases and endothelial dysfunction. World J Surg 31: 632-643.
40. Park IW, Ullrich CK, Schoenberger E, Ganju RK, Groopman JE,. 2001. HIV-1 Tat induces microvascular endothelial apoptosis through caspase activation. J Immunol 167: 2766-2771.
41. Pasquinelli G, Tazzari PL, Vaselli C, Foroni L, Buzzi M, Storci G, Alvaino F, Ricci F, Bonafà M, Orrico C, Bagnara GP, Stella A, Conte R,. 2007. Thoracic aortas from multiorgan donors are suitable for obtaining resident angiogenic mesenchymal stromal cells. Stem Cells 25: 1627-1634.
42. Pasquinelli G, Pacilli A, Alviano F, Foroni L, Ricci F, Valente S, Orrico C, Lanzoni G, Buzzi M, Tazzari PL, Pagliaro PP, Stella A, Bagnara GP,. 2010. Multidistrict human mesenchymal vascular cells: Pluripotency and stemness characteristics. Cytotherapy 12: 275-287.
43. Rusnati M, Coltrini D, Oreste P, Zoppetti G, Albini A, Noonan D, d'Adda di Fagagna F, Giacca M, Presta M,. 1997. Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size. J Biol Chem 272: 11313-11320.
44. Tang T, Boyle JR, Dixon AK, Varty K,. 2005. Inflammatory abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 29: 353-362.
45. Taylor JP, Pomerantz R, Bagasra O, Chowdhury M, Rappaport J, Khalili K, Amini S,. 1992. TAR-independent transactivation by Tat in cells derived from the CNS: A novel mechanism of HIV- 1 gene regulation. EMBO J 11: 3395-3403.
46. Ullrich CK, Groopman JE, Ganju RK,. 2000. HIV-1 gp120- and gp160-induced apoptosis in cultured endothelial cells is mediated by caspases. Blood 96: 1438-1442.
47. Urbinati C, Mitola S, Tanghetti E, Kumar C, Waltenberger J, Ribatti D, Presta M, Rusnati M,. 2005. Integrin alphavbeta3 as a target for blocking HIV-1 Tat-induced endothelial cell activation in vitro and angiogenesis in vivo. Arterioscler Thromb Vasc Biol 25: 2315-2320.
48. Veschambre P, Simard P, Jalinot P,. 1995. Evidence for functional interaction between the HIV-1 Tat transactivator and the TATA box binding protein in vivo. J Mol Biol 250: 169-180.
49. Yeh WC, Cao Z, Classon M, McKnight SL,. 1995. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev 9: 168-181.
50. Zauli G, Gibellini D,. 1996. The human immunodeficiency virus type-1 (HIV-1) Tat protein and Bcl-2 gene expression. Leuk Lymphoma 23: 551-560.
51. Zauli G, Catani L, Gibellini D, Re MC, Vianelli N, Colangeli V, Celeghini C, Capitani S, La Placa M,. 1996. Impaired survival of bone marrow GPIIb/IIa+ megakaryocytic cells as an additional pathogenetic mechanism of HIV-1-related thrombocytopenia. Br J Haematol 92: 711-717.